18
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T63017 | SphK2-IN-2 | ||
SphK2-IN-2 (21g) is a potent and selective inhibitor of SphK2 (IC50: 0.23 μM). | |||
T63618 | SphK2-IN-1 | ||
SphK2-IN-1 is an SphK2 inhibitor with an IC50 value of 0.359 μM. SphK2-IN-1 can be used to study cancer, inflammation, neurological and cardiovascular diseases. | |||
TQ0138 | K145 hydrochloride | Apoptosis , S1P Receptor | |
K145 hydrochloride is a selective sphk2 inhibitor with substrate competitiveness and oral activity, with IC50 of 4.3 µM and Ki of 6.4 µM. K145 hydrochloride can induce apoptosis and has strong antitumor activity. | |||
T6750 | Opaganib | ABC294640 | S1P Receptor |
Opaganib (ABC294640) is an orally active and specific sphingosine kinase-2 (SphK2) inhibitor (IC50: 60 μM). | |||
T63047 | SLP9101555 | S1P Receptor , LPL Receptor | |
SLP9101555 is a potent and selective sphingosine kinase 2 (SphK2) inhibitor with a Ki of 90 nM.SLP9101555 has a high affinity for SphK2, which is 200-fold higher than that of SphK1.SLP9101555 dramatically reduces extrace... | |||
T8840 | PF-543 hydrochloride | PF-543 | Apoptosis , S1P Receptor , Autophagy , LPL Receptor |
PF-543 hydrochloride (PF-543) inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform. | |||
T16128 | MP-A08 | S1P Receptor | |
MP-A08 is a highly selective ATP competitive inhibitor of sphingosine kinase (SPHK1) that targets both SphK1 and SphK2 (Ki: 6.9 ± 0.8 μM and 27 ± 3 μM, respectively). | |||
T6085 | PF-543 | Sphingosine Kinase 1 Inhibitor II,PF 543 | Apoptosis , S1P Receptor , Autophagy , LPL Receptor |
PF-543 (Sphingosine Kinase 1 Inhibitor II), a novel sphingosine-competitive inhibitor of SphK1, inhibits SphK1 with IC50 and Ki of 2.0 nM and 3.6 nM. | |||
T9014 | SKI-178 | Apoptosis , S1P Receptor | |
SKI-178 is a sphingosine kinase 1 (SphK1) inhibitor with IC50 of 0.1-1.8 μM. It induces prolonged mitosis followed by apoptotic cell death through the intrinsic apoptotic cascade. The sustained activation of CDK1 during ... | |||
T11739 | K145 | Others | |
K145 is inactive against SphK1 and other protein kinases. K145 induces cell apoptosis and has potently antitumor activity. K145 is a selective, substrate-competitive and orally active SphK2 inhibitor with an IC50 of 4.3 ... | |||
T28806 | SLM6031434 HCl | SLM 6031434,SLM6031434,SLM-6031434 | |
SLM6031434 is selective inhibitor of SphK2. | |||
T28803 | SLC5111312 HCl | SLC5111312 hydrochloride,SLC 5111312,SLC-5111312,SLC5111312 | |
SLC5111312 is an inhibitor of SphK1 and SphK2. | |||
T28802 | SLC4101431 | SLC-4101431,SLC 4101431 | |
SLC4101431 is a potent SphK2 inhibitor with Ki value of 90 nM. | |||
T70071 | SLM6031434 (free base) | ||
SLM6031434 (free base) is an inhibitor of sphingosine kinase type 2 (SphK2). It consists of pedant 1-guanidino-2-phenyloxadiazolylpyrrolidine group. | |||
T83883 | Biotin Sphingosine | Biotinyl Sphingosine | |
Biotin sphingosine, a biotinylated derivative of sphingosine (d18:1), serves as a probe in assays for detecting the phosphorylation activity of sphingosine kinase 1 (SPHK1) and SPHK2 in cell lysates. | |||
T63132 | Amgen-23 | ||
Amgen-23 (compound 23) is a potent inhibitor of sphingosine kinase (SPHK), acting on SPHK1 (IC50: 20 μM) and SPHK2 (IC50: 1.6 μM). amgen-23 can be used in anticancer studies. | |||
T63835 | SphK1-IN-2 | ||
SphK1-IN-2 is a potent and selective SphK1 inhibitor that acts on both SphK1 (IC50: 19.81 nM) and SphK2 (IC50>10 nM). sphK1-IN-2 induces cell cycle arrest and apoptosis, exhibits anti-proliferative effects, and can be us... | |||
T70900 | VT-ME6 | ||
VT-ME6 is a potent and selective sphingosine kinase 2 inhibitor. VT-ME6, contained a quaternary ammonium group as a warhead and established that a positively charged moiety is necessary for engaging key amino acid residu... |